The combination of resveratrol and quercetin reduced P2Y2R expression and ameliorated high-fat-induced hepatic steatosis and NAFLD by enhancing fatty acid oxidation via P2Y2R/AMPK pathway (54). Here, P2RY2 is linked to fatty liver disease.